Spots Global Cancer Trial Database for A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)
Official Title: A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)
Study ID: NCT00238875
Conditions
Interventions
Study Description
Brief Summary: To evaluate the efficacy and safety of SBRT for T1N0M0 non-small cell lung cancer
Detailed Description: To evaluate the efficacy and safety of SBRT for T1N0M0 non-small cell lung cancer，the following questions should be answered. Can SRT be an alternative standard treatment modality for inoperable patients? Can SRT can be a comparable standard treatment modality with lobectomy for operable patients? 12 Gy is the daily dose at the isocenter，and 48 Gy in total by 4 fractions will be irradiated by stereotactic irradiation over 4 to 8 days.
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kyushu University Hospital, Fukuoka,Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan
Hiroshima University, School of Medicine, Hiroshima,Minami-ku,Kasumi,1-2-3, Hiroshima, Japan
Hokkaido University Hospital, North-14 West-5 Kita-ku,Sapporo, Hokkaido, Japan
Sapporo Medical University, S-1,W-16,Chuo-ku,Sapporo, Hokkaido, Japan
Institute of Biomedical Research and Innovation Hospital, Kobe,Chuo-ku,Minatojima-Minamimachi,2-2, Hyogo, Japan
Kitasato University School of Medicine, Sagamihara,Kitasato,1-15-1, Kanagawa, Japan
Kyoto Universlty Hospital, Kyoto,Sakyoku,Shogoin,Kawahara-cho,54, Kyoto, Japan
Tohoku University Hospital, Sendai,Aoba-ku,Seiryo-machi,1-1, Miyagi, Japan
Tenri Hospital, Tenri,Mishima-cho,200, Nara, Japan
The University of Tokyo Hospital, Bunkyo-ku,Hongo,7-3-1, Tokyo, Japan
Tokyo Metropolitan Komagome Hospital, Bunkyo-ku,Honkomagome,3-18-22, Tokyo, Japan
Nihon University Itabashi Hospital, Itabashi-ku,Oyaguchikamimachi,30-1, Tokyo, Japan
Cancer Institute Hospital, Koto-ku,Ariake,3-10-6, Tokyo, Japan
Tokyo Women's Medical University, Shinjuku-ku,Kawada-cho,8-1, Tokyo, Japan
Keio University Hospital, Shinjuku-ku,Shinanomachi,35, Tokyo, Japan
University of Yamanashi Faculty of Medicine, Nakakoma,Tamaho,Shimokato,1110, Yamanashi, Japan
Contact Details
Name: Masahiro Hiraoka, MD, PhD
Affiliation: Kyoto Universlty Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
